Company profile
Reata Pharmaceuticals Inc Insider Trading
RETAEvery SEC Form 4 insider trading filing for Reata Pharmaceuticals Inc (RETA) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Sector
- Pharmaceutical Preparations
- CIK
- 0001358762
- Filings
- 52
- Insiders
- 18
- Last filing
- 2023-09-26
Activity summary
No insider transactions in the last 30 days. The most recent was on September 26, 2023, when McClellan William D. Jr. sold 99 shares. 52 filings from 18 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q2 23 to Q3 23. Reata Pharmaceuticals Inc insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $23.0M.
No insider activity recorded for RETA in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 26, 2023 | McClellan William D. Jr. | RETA | Disposition | 99 | — | — |
| Sep 26, 2023 | McClellan William D. Jr. | RETA | Disposition | 2,137 | — | — |
| Sep 26, 2023 | McClellan William D. Jr. | RETA | Disposition | 6,300 | — | — |
| Sep 26, 2023 | McClellan William D. Jr. | RETA | Disposition | 5,000 | — | — |
| Sep 26, 2023 | McClellan William D. Jr. | RETA | Disposition | 135 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=RETA" \
-H "X-Api-Key: $KEY"